Study shows how troriluzole can target early-stage alterations associated with Alzheimer’s

  • Post author:
  • Post category:uncategorized

In a recent development in Alzheimer’s disease research, Auburn University scientists have studied a new drug, troriluzole, that can prevent brain changes leading to memory loss and cognitive decline in a mouse model of the disease.